IP Library Granted Patent US 8,697,238
Granted Patent B2
US 8,697,238 · App. 12/225,758 · Granted Apr 15, 2014

Biomaterial, joint prosthesis using the biomaterial and method of producing the same

Inventors: Masayuki Kyomoto (Tokyo, JP); Kazuhiko Ishihara (Tokyo, JP); Yasuhiko Iwasaki (Tokyo, JP); Toru Moro (Tokyo, JP); Kozo Nakamura (Tokyo, JP); Yoshio Takatori (Tokyo, JP); Hiroshi Kawaguchi (Tokyo, JP); Tomohiro Konno (Tokyo, JP); Noboru Yamawaki (Osaka, JP)
Assignees: Kyocera Medical Corporation; The University of Tokyo; National University Corporation Tokyo Medical and Dental University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,697,238
App. No.
12/225,758
Granted
Apr 15, 2014
Kind
B2
Abstract

The object of the present invention is to provide a joint prosthesis, bearing material and a production method thereof, which suppresses wear in a sliding section and suppresses the production of abrasive powder even during repeated daily operation. To achieve the object, there is provided a biomaterial comprising: a substrate made of metal, alloy or ceramic; and a biocompatible material layer laminated on the substrate, wherein hydroxyl groups are formed on the substrate by surface-treating, while the biocompatible material layer comprises a polymer containing phosphorylcholine groups, the substrate and the biocompatible material layer are bound via a binder layer which is combined with the hydroxyl groups of the substrate and with the biocompatible material layer.

Claims (20)

1. A biomaterial comprising:

a substrate made of at least one selected from the group consisting of metal, alloy and ceramic; and

a biocompatible material layer laminated on appropriate sections of the substrate,

wherein:

hydroxyl groups are formed on a surface of the substrate by surface-treating at least one section of the surface, while the biocompatible material layer comprises a polymer containing phosphorylcholine groups,

the substrate and the biocompatible material layer are bound via a binder layer, the binder layer being combined, on the one hand, with the hydroxyl groups of the substrate by graft-polymerization and, on the other hand, with the biocompatible material layer by graft-polymerization respectively,

the binder layer contains an organic compound having carboxyl groups on the one terminal and methacrylic groups or methylene groups on the other terminal, the carboxyl groups on the one terminal are combined with the hydroxyl groups, and

the methacrylic groups or the methylene groups on the other terminal are combined with the polymer containing phosphorylcholine groups by graft-polymerization into the formation of covalent bonds.

2. The biomaterial according to claim 1 , wherein the polymer containing phosphorylcholine groups includes 2-methacryloyloxyethyl phosphorylcholine polymer and a copolymer containing 2-methacryloyloxyethyl phosphorylcholine.

3. The biomaterial according to claim 1 , wherein the substrate made of metal, alloy or ceramic contains a metal oxide or metal component capable of forming hydroxyl groups.

4. The biomaterial according to claim 1 , wherein the substrate is made of titanium metal, or at least one alloy selected from the group consisting of cobalt-chromium alloy, cobalt- chromium -molybdenum alloy, nickel-chromium alloy, stainless steel alloy and titanium alloy, or a ceramic containing at least one substance selected from the group consisting of alumina, zirconia and titania.

5. The biomaterial according to claim 1 , wherein the substrate comprises at least one selected from the group consisting of chromium and titanium,

a surface of chromium or titanium is oxidized by oxygen-plasma treatment to form hydroxyl groups thereon.

6. The biomaterial according to claim 1 , wherein the binder layer is made of at least one selected from the group consisting of 4- methacryloxyethyltrimellitate anhydride, 4-methacryloyloxy ethyl trimellitic acid, methacrylic acid, maleic anhydride and maleic acid.

7. A prosthesis comprising the biomaterial according to claim 1 .

8. A prosthesis comprising the biomaterial according to claim 2 .

9. A prosthesis comprising the biomaterial according to claim 3 .

10. A prosthesis comprising the biomaterial according to claim 4 .

11. A prosthesis comprising the biomaterial according to claim 5 .

12. A prosthesis comprising the biomaterial according to claim 6 .

Assignments (3)
MERGER Recorded Dec 29, 2017
From: KYOCERA MEDICAL CORPORATION
To: KYOCERA CORPORATION
Reel/Frame 044504/0082 →
CHANGE OF NAME Recorded Feb 20, 2014
From: JAPAN MEDICAL MATERIALS CORPORATION
To: KYOCERA MEDICAL CORPORATION
Reel/Frame 032288/0560 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2010
From: KYOMOTO, MASAYUKI; ISHIHARA, KAZUHIKO; IWASAKI, YASUHIKO; MORO, TORU; NAKAMURA, KOZO; TAKATORI, YOSHIO; KAWAGUCHI, HIROSHI; KONNO, TOMOHIRO; YAMAWAKI, NOBORU
To: JAPAN MEDICAL MATERIALS CORPORATION; THE UNIVERSITY OF TOKYO; NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY
Reel/Frame 024559/0613 →
Priority Claims (1)
JP 2006-091544 · Mar 29, 2006 · national
Continuity (1)
Related Publication 20100262237A1 · Oct 14, 2010